Clinical Trial Update: Hyperpolarized Carbon-13 (13C) Pyruvate Imaging in Patients With Glioblastoma [Phase 1]

View source ↗

Summary

Phase 1 trial of hyperpolarized carbon-13 pyruvate imaging in glioblastoma patients has completed, evaluating this metabolic imaging approach for GBM characteri…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Glioblastoma

Drugs mentioned

• Hyperpolarized Carbon-13 Pyruvate Imaging (13C-pyruvate)

Snippet

Sponsor: Susan Chang | Conditions: Glioblastoma Multiforme (GBM) | Phase 1 | Status: COMPLETED